Minoxidil
Always use this medicine exactly as described in this leaflet or as directed by your doctor or pharmacist.
Alocutan is indicated for the treatment of female pattern hair loss.
Alocutan is used to treat androgenetic alopecia (excessive hair loss)
in women (characteristic, diffuse, thinning of hair on the front-top area of the scalp in women). Treatment with Alocutan stimulates hair growth
and counteracts the progression of androgenetic alopecia.
The onset of androgenetic alopecia in women is characterized by a decrease in hair thickness on the top and frontal area of the scalp, with preservation of the hairline. There is thinning of hair covering the central part of the scalp, but complete baldness is very rare.
The following illustrations show the stages of female pattern hair loss for which the efficacy of Alocutan has been demonstrated.
Before starting treatment with Alocutan, discuss it with your doctor or pharmacist.
You should rule out hormonal causes, underlying diseases, or malnutrition. In these cases, you will need special treatment.
Alocutan should only be applied to healthy, non-damaged scalp. Do not use Alocutan if the cause of hair loss is unknown, if you have hair loss after childbirth, if your scalp is infected or inflamed.
In case of systemic effects (systemic action) or severe skin reactions, discontinue use.
Alocutan is for external use on the scalp only. Do not use Alocutan on other parts of the body.
Do not use Alocutan:
Stop using Alocutan and consult your doctor if:
If the medicine comes into contact with areas other than the scalp, unwanted hair growth may occur in those areas.
Patients with very light hair have reported isolated cases of slight changes in hair color (slight discoloration of blonde hair) during concomitant use of the medicine and other hair care products or after bathing in heavily chlorinated water.
Accidental ingestion may lead to severe side effects from the cardiovascular system. Therefore, this medicine should be kept out of the reach of children.
There have been cases of excessive hair growth on the body of infants following skin contact with minoxidil application sites in patients (caregivers) using topical minoxidil. Hair growth returned to normal within a few months when the infant was no longer exposed to minoxidil. Be careful to avoid children coming into contact with areas of the body where minoxidil has been applied topically.
If excessive hair growth on the body is observed in a child during the use of topical minoxidil products, consult a doctor.
Avoid inhaling the medicine during application.
This medicine is not recommended for use in children and adolescents under 18 years of age, as the safety and efficacy have not been established in this age group.
Tell your doctor or pharmacist about all the medicines you are taking, have recently taken, or might take.
There is no available information on interactions between Alocutan and other medicines.
Although not clinically confirmed, there is a theoretical possibility that absorbed minoxidil may enhance orthostatic hypotension (blood pressure drop when changing position from lying to standing) in patients taking concomitant peripheral vasodilators used to treat high blood pressure.
Alocutan should not be used with other dermatological medicines (external use products containing corticosteroids, retinoids, or ditranol) or with medicines that increase the absorption of the active substance through the skin.
There are only limited data on the use of Alocutan in pregnant women. Absorbed minoxidil may pass into breast milk. Therefore, Alocutan should not be used in pregnant or breastfeeding women.
This medicine may cause dizziness or hypotension (see section 4). If you experience symptoms, do not drive or operate machinery.
This medicine contains 199 mg of propylene glycol (E 1520) per ml.
This medicine contains 494 mg of alcohol (ethanol) per ml.
The medicine may cause burning of damaged skin.
Alcohol may cause burning and irritation of the eyes. In case of accidental contact with sensitive areas (eyes, damaged skin, mucous membranes), rinse the affected area with plenty of water.
Alocutan contains ethanol and propylene glycol, so repeated spraying on hair instead of the scalp may lead to increased dryness and/or stiffness of the hair.
Always use this medicine exactly as described in this leaflet or as directed by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
Alocutan is for external use on dry scalp only. Apply Alocutan only to healthy, undamaged scalp and use it every time as described below. Do not use Alocutan on parts of the body other than the scalp.
Recommended dose
Unless your doctor has told you otherwise, use Alocutan as follows.
Apply 1 ml of Alocutan to the affected area of the scalp twice a day (morning and evening).
Do not exceed the daily dose of 2 ml, regardless of the size of the affected area.
Use in children and adolescents
Alocutan should not be used in children and adolescents under 18 years of age, as there are no available results from controlled clinical trials on its efficacy and safety in these age groups.
For cutaneous use (scalp).
Each pack of Alocutan contains two different applicators for the spray pump:
Both applicators can be exchanged by detaching one applicator and replacing it with the other.
To obtain a single dose of 1 ml of solution, 6 sprays of the aerosol are required.
Instructions for use/application
Spray the solution directly onto the scalp in the area of hair loss. To do this, press the pump 6 times. After each pump press, spread the liquid with your fingertips over the affected area, avoiding inhalation of the sprayed mist.
After applying Alocutan, wash your hands carefully to avoid accidental contact with mucous membranes and eyes. After applying Alocutan, you can style your hair as usual.
However, do not wet your scalp for about 4 hours. This will prevent Alocutan from being washed off.
The onset and degree of hair regrowth vary among patients.
To see effects, treatment is usually started with application of the medicine twice a day for a period of 2 to 4 months. To maintain the effect, continued use is recommended without interruption, twice a day.
Using more Alocutan or using it more often will not lead to better results.
There is sufficient clinical experience regarding the possible therapeutic effect in case of treatment for up to 48 weeks.
If there is no improvement after 8 months, treatment should be stopped.
During treatment of hair follicles with minoxidil, the resting phase (telogen) in the hair growth cycle is shortened, and the transition to the growth phase (anagen) occurs faster. This stimulates the growth of new hair, causing old, inactive hair to fall out. As a result, there may initially be a feeling of increased hair loss.
In some patients, this reaction is observed within 2 to 6 weeks after starting treatment with minoxidil. However, do not be concerned, as this reaction is related to hair regrowth. This effect subsides within a few weeks and may be considered the first sign of minoxidil's effect.
If you feel that Alocutan is too strong or too weak, you should contact your doctor or pharmacist.
Using Alocutan in doses higher than recommended and on relatively large areas of the body or on other areas of the body than the scalp may lead to increased systemic absorption of minoxidil. To date, no cases of poisoning due to topical application of a minoxidil solution have been reported.
Given the concentration of the active substance in Alocutan, accidental ingestion may lead to systemic effects, such as those that occur after ingestion of the active substance, e.g., in tablet form. This may lead to the following side effects: rapid heartbeat, low blood pressure, fluid retention, and consequently sudden weight gain, dizziness.
In case of accidental ingestion of the medicine or if you experience symptoms of overdose, inform your doctor immediately so that they can decide what to do next. Bring the package of the medicine with you to inform the doctor which active substance was taken.
Do not take a double dose to make up for a forgotten dose. Continue treatment, using the recommended dose. Making up for a forgotten dose will not provide any benefit and may lead to side effects.
Continue treatment to improve and maintain hair growth. Otherwise, hair loss will recur.
If treatment with Alocutan is stopped, hair loss will recur within 3 to 4 months, and the condition will return to what it was before treatment.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Frequency not known(frequency cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse. You can also report side effects directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and bottle after EXP. The expiry date refers to the last day of that month.
Do not freeze.
Contains flammable ethanol. Keep away from heat sources or open flames.
Shelf life after first opening of the bottle: 6 weeks.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Alocutan is a clear, colorless to light yellow solution available in the following packs: 1 x 60 ml and 3 x 60 ml solution for cutaneous use in white HDPE bottles with a spray pump, in a cardboard box.
Each pack contains two applicators: one pre-mounted and one with an extended tip.
Not all pack sizes may be marketed.
SUN-FARM Sp. z o.o.
ul. Dolna 21
05-092 Łomianki
mibe GmbH Arzneimittel
Münchener Straße 15
06796 Brehna
Germany
SUN-FARM Sp. z o.o.
ul. Dolna 21
05-092 Łomianki
Austria
Alocutan 20 mg/ml Lösung zur Anwendung auf der Haut
Germany
Minoxicutan Frauen 20 mg/ml Lösung zur Anwendung auf der Haut (Kopfhaut)
Poland
Alocutan
Date of last revision of the leaflet:09.2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.